TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) Long Term Investor Investigation Over Potential Breaches Of Fiduciary Duties

  • If you are a current long-term investor in shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Jan. 28, 2014 (Update) -- On January 24, 2014, SciClone Pharmaceuticals, Inc. announced that the Audit Committee of the Company's Board of Directors has appointed PricewaterhouseCoopers Zhong Tian LLP to replace PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm, effective January 24, 2014. Shares of SciClone Pharmaceuticals, Inc. declined from ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: